HIV Treatment Adherence

Submitted by hiv-info-adm on

Key Points

  • Treatment adherence includes starting HIV treatment, keeping all medical appointments, and taking HIV medicines exactly as prescribed.

Drug Resistance

Submitted by hiv-info-adm on

Key Points

  • HIV mutations sometimes develop while a person is taking HIV medicines, which may cause drug-resistant HIV that can be transmitted to other people.
  • Once drug resistance develops, HIV medicines that previously controlled a person’s HIV are no longer effective.

Post-Exposure Prophylaxis (PEP)

Submitted by hiv-info-adm on

Key Points

  • Post-exposure prophylaxis (PEP) refers to a short course (28 days) of HIV medicines that are taken after a possible exposure to prevent HIV infection.
  • PEP must be started within 72 hours after a possible exposure to HIV. The sooner PEP is started after a possible HIV exposure, the better.

Pre-Exposure Prophylaxis (PrEP)

Submitted by hiv-info-adm on

Key Points

  • Pre-exposure prophylaxis (PrEP) is an HIV medicine taken by people who do not have HIV that reduces the risk of getting HIV from sex by about 99% and from injection drug use by at least 74%.
  • Although PrEP protects against HIV during sex without a condom or if a condom fails, it does not protect against other sexually transmitted infections (STIs) an